EpiPen manufacturer settles $30 million claim; THC-containing brands cited as potential cause of vaping epidemic; Idaho submits work-requirement waiver for Medicaid expansion.
EpiPen manufacturer Mylan NV has agreed to pay $30 million in restitution for charges by the US Securities and Exchange of Commission, which allege that the manufacturer failed to disclose a possible loss related to a previous federal probe into whether they overcharged Medicaid for their product, according to The Wall Street Journal. Back in 2016, Mylan NV agreed to pay $465 million to settle allegations from the US Department of Justice stating they wrongly classified the EpiPen as a generic product rather than a brand product. As drug manufacturers are required by law to pay rebates for sales to patients insured by Medicaid, this wrongful classification allowed the EpiPen manufacturer to pay a smaller rebate on sales to Medicaid programs, which is funded jointly by the federal government and the respective states.In a report examining a smaller group of vapers, health officials in Illinois and Wisconsin said about two-thirds of illnesses were related to a THC product brand called “Dank Vapes,” which are sold in cartridges and obtained from non-retail sources like friends, family, or street suppliers, according to USA Today. The CDC said that of the 514 affected patients who reported details on their use of vaping devices and e-liquids, 77% used products that contained THC alone or combined with nicotine. The role of THC-related products in causing nearly 4 in 5 cases has alerted health officials to their potential role in the outbreak. Additional THC-containing brands cited in the report were TKO, Off White, Moon Rocks, Chronic Carts, Cookies, Smart Carts, and Kingpen.Last Friday, Idaho officials submitted a work requirement waiver to the HHS for Medicaid expansion, with 4 other waivers likely to be submitted by December, according to The Associated Press. Waivers are required by states who are seeking to deviate from standard Medicaid rules. Earlier this year, Idaho officials added restrictions to voter-approved Medicaid expansion that passed in November, which requires a waiver. The work waiver would require recipients aged 19 to 59 years to work 20 hours weekly to remain eligible for Medicaid, apart from those with medical conditions. The Idaho Department of Health & Welfare is additionally taking public comments on another waiver, taking steps to fix problems with a rejected waiver, and is negotiating with the federal agency.
Sociodemographic Factors Impact Cytoreductive Surgery Decisions in Advanced Ovarian Cancer
April 9th 2025Patients with advanced epithelial ovarian cancer who were non-Hispanic Black, older, had lower household income, resided in nonmetropolitan areas, and were unmarried had higher odds of refusing cytoreductive surgery.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Lp(a) and Getting a Head Start Against Heart Disease: Jeremy Wigginton, MD
April 8th 2025Lipoprotein a (Lp[a]) is a valuable tool for assessing a patient's risk of cardiovascular disease, which can facilitate earlier intervention efforts and reduce health care costs, argued Jeremy Wigginton, MD.
Read More